[1] 刘宝军,郑茂荣,周鼎耀,等.银屑病患者血和皮损处血小板活化因子生物测定.中华皮肤科杂志,1992,52:232.
[2] Pincellin C,Fantini F,Romualdi P,et al.Substance P is diminishcd and vasoactive intestinal peptjde 15 augmented in psoriatic Iesions and these peptides exero disparate effects on the Proliferatjon of culturcd human.keratinocytes.J Invest Dermatol,1992,98:421.
[3] Hirata F,Schiffmann E,Venkatasubrarnanian K,et al.A PhosPlioliPase A2 inhibitory Protcill in rabbit ncutrophils induced by glucocorticoids.Proc Natl Sci Acad USA,1980,77:2533.
[4] Wallncr BP.Mattaliano RJ.Hession C,et al.Cloning and expression of human liPocortin,a PhosPholiPase A2 inhibitor with Potential anti-inflammatory.Nature,1986,320:77.
[5] Aarsnian AJ,MynbcekH,van den Bosch H,et al.Lipocortin inhibition of extracellular and intraccllular PhosPholiPases A2 15 substrate conccntration dePendent FEBS Lett,1987,219:176.
[6] Norris JFB,IldertonE,Yard]ey HJ,et al.Utllization of epiderrnal phospholiPase A2 inhibition to monitor toPical ster、id action.Br J Dermotol,1984,111(Suppl 27):195.
[7] Ilchyshyn A,IldertonE,KingsburyJ,et al.Use of uninvolved Psoriatic epiderrnis as an in vitro xnodel testing the anti-nospholipase activity of glucocorticoids.Skin Mcdels.Marks R,cds.Berling:SPringer,1986:292~296.
[8] Cartwright PH,llderton E.Sowden JM,et al.Inhibition of normal and Psoriatic epidermal phospholipase A2 by picomolar concentrations of recoml〕inant human liPocortin I.Br J Dermatol,1989,121:155. |